Medicine
Carbidopa and Levodopa 10 mg/100 mg orally disintegrating tablet
Carbidopa and Levodopa 10 mg/100 mg orally disintegrating tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Carbidopa and Levodopa
- Brand
- Sold under the generic name
- Strength
- 10 mg/100 mg
- Dosage form
- Orally disintegrating tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 2 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15° to 30°C (59° to 86°F). Protect from moisture and light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BA02 Carbidopa and Levodopa
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 December 2014
- Identifiers
- RxCUI 476399, 476515, 483090DailyMed set ID 302bfe03-d222-4a87-80ff-f2dbfb9a07f4, 48e0f2ec-b217-4c25-a71c-20e173d05edbNDC 16571-157, 47335-186Application ANDA078893, ANDA078690
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, orally disintegrating in 1 bottle | 47335-186-08 | Sun Pharmaceutical IndustriesIndia | 15 December 2014 |
| 1000 tablet, orally disintegrating in 1 bottle | 47335-186-18 | Sun Pharmaceutical IndustriesIndia | 15 December 2014 |
| 30 tablet, orally disintegrating in 1 bottle | 47335-186-83 | Sun Pharmaceutical IndustriesIndia | 15 December 2014 |
| 100 tablet, orally disintegrating in 1 bottle | 47335-186-88 | Sun Pharmaceutical IndustriesIndia | 15 December 2014 |
| 100 tablet, orally disintegrating in 1 bottle, plastic | 16571-157-01 | Rising Pharma Holdings | 8 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Carbidopa and Levodopa
Clinical summary
Carbidopa and Levodopa is a fixed-dose combination medicine indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. MedsAcross supplies Carbidopa and Levodopa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Carbidopa and LevodopaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SINEMET prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
- Hopledo: European public assessment report (EPAR) · European Medicines Agency
- Onerji: European public assessment report (EPAR) · European Medicines Agency
Need Carbidopa and Levodopa 10 mg/100 mg orally disintegrating tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.